BERWYN, PA — AscellaHealth has introduced its latest initiative, the AscellaHealth Podcast Pulse, a platform delving into the critical issues shaping the future of global life sciences and healthcare. This podcast series features discussions with industry leaders, offering insights into pressing challenges and innovative solutions impacting clients, partners, and patients worldwide.
Dea Belazi, CEO of AscellaHealth, emphasized the podcast’s role in facilitating change, stating, “This podcast series provides a platform for gathering industry insights and the perspectives of thought leaders on opportunities to address key challenges facing our clients, partners, and patients worldwide.” The series promises engaging dialogues with experts, covering topics such as clinical trial customization, specialty drug cost management, and patient advocacy.
The inaugural episode features Donovan Quill, Executive VP of Business Development, Growth & Strategy, conversing with Gillian Molloy, VP of Market Access. They explore the intricacies of commercializing therapies for rare diseases, focusing on early planning and the specialty pharmacy market.
Quill highlights the podcast’s potential, saying, “I look forward to using AscellaHealth Podcast Pulse as a platform for AscellaHealth’s internal and external life sciences industry leaders to insight and uplift conversations surrounding the everchanging life sciences industry, especially within the rare and orphan disease space.”
Listeners can access AscellaHealth Podcast Pulse on AscellaHealth’s website and Spotify, offering a new way to engage with the forefront of life sciences innovation.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.